Search
for
Sort by
Research 30 of 44
- Dermatological adverse events with taxane chemotherapy
- Permanent chemotherapy-induced alopecia: Case report and review of the literature
- Irreversible and severe alopecia following docetaxel or paclitaxel cytotoxic therapy for breast cancer
- Cutaneous Reactions to Chemotherapeutic Agents
- Weekly docetaxel in minimally pretreated cancer patients: A dose-escalation study focused on feasibility and cumulative toxicity of long-term administration
- Cutaneous angiosarcoma of the face and scalp presenting as alopecia
- High incidence of severe hand–foot syndrome during capecitabine–docetaxel combination chemotherapy
- Impact of Reporter Type on Signal Detection of Cancer Therapy-Induced Alopecia: A Hypothesis-Generating Study Using the FDA Adverse Event Reporting System
- Impact of Reporter Type on Signal Detection of Cancer Therapy–Induced Alopecia: A Hypothesis-Generating Study Using the FDA Adverse Event Reporting System
- 203 Inhibin A is downregulated during chemotherapy in patients with breast cancer
- Docetaxel.
- An overview of management of drug-induced hair and nail disorders
- Docetaxel and oxaliplatin in the second-line treatment of platinum-sensitive recurrent ovarian cancer: a phase II study
- Low Intensity Ultrasound as an Antidote to Taxane/Paclitaxel-induced Cytotoxicity
- Mucocutaneous reactions to chemotherapy
- Hair and cancer chemotherapy: consequences and nursing care - a literature study
- Lupus erythematosus: systemic and cutaneous manifestations
- Docetaxel, cisplatin and 5-fluorouracil in patients with locally advanced unresectable head and neck cancer: a phase I–II feasibility study
- Presentation, impact and prevention of chemotherapy-induced hair loss: scalp cooling potentials and limitations
- Permanent Chemotherapy-Induced Alopecia in Patients with Breast Cancer: A 3-Year Prospective Cohort Study
- Hair disorders in patients with cancer
- Steroidal 5α-reductase and 17α-hydroxylase/17,20-lyase (CYP17) inhibitors useful in the treatment of prostatic diseases
- Emerging treatments in alopecia
- First-line therapy with gemcitabine and paclitaxel in locally, recurrent or metastatic breast cancer: A phase II study
- Persistent major alopecia following adjuvant docetaxel for breast cancer: incidence, characteristics, and prevention with scalp cooling
- Chemotherapy-induced iatrogenic injury of skin: New drugs and new concepts
- An Overview of Chemotherapy Side Effects on Patients with Prostate Cancer, Bladder Cancer, and Testicular Cancer at Haji Adam Malik General Hospital Medan from 2020-2022
- Docetaxel-induced Psoriasis
- Periungual lesions secondary to chemotherapy with docetaxel
- Index